Y-Intercept (HK)’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30,282
| Closed | -$2.07M | – | 1712 |
|
|
2025
Q1 | $2.07M | Buy |
30,282
+13,698
| +83% | +$935K | 0.14% | 184 |
|
|
2024
Q4 | $1.29M | Sell |
16,584
-47,164
| -74% | -$3.67M | 0.09% | 331 |
|
|
2024
Q3 | $4.27M | Buy |
63,748
+57,427
| +909% | +$3.85M | 0.26% | 65 |
|
|
2024
Q2 | $717K | Buy |
6,321
+1,583
| +33% | +$179K | 0.04% | 653 |
|
|
2024
Q1 | $657K | Buy |
+4,738
| New | +$657K | 0.05% | 572 |
|
|
2023
Q4 | – | Sell |
-25,582
| Closed | -$2.39M | – | 1329 |
|
|
2023
Q3 | $2.39M | Buy |
25,582
+14,336
| +127% | +$1.34M | 0.23% | 106 |
|
|
2023
Q2 | $1.45M | Buy |
11,246
+4,910
| +77% | +$631K | 0.15% | 175 |
|
|
2023
Q1 | $736K | Sell |
6,336
-12,154
| -66% | -$1.41M | 0.09% | 359 |
|
|
2022
Q4 | $2.09M | Buy |
+18,490
| New | +$2.09M | 0.31% | 51 |
|
|
2022
Q1 | – | Sell |
-9,800
| Closed | -$1.32M | – | 778 |
|
|
2021
Q4 | $1.32M | Buy |
+9,800
| New | +$1.32M | 0.31% | 72 |
|